Prostate cancer patients starting treatment with androgen deprivation therapy (ADT) who were already taking cholesterol-lowering statins had a 10-month prolonged time to cancer progression compared with patients who were not on statins, according to the results of a new study published in JAMA Oncology. – See more at: Statins Benefit ADT-Treated Prostate Cancer Patients | Cancer Network.
This study reported men starting on hormonal therapy who already were taking statin therapy for high cholesterol had better results than men not taking statins.
There have been many studies that show that taking statins help reduce the risk of prostate cancer recurrence.
I encourage patients that have borderline high cholesterol to speak to their primary care doctors about starting on statin therapy.